Oncology

Publications

Adeyemi, A; Gross, AM; Baldwin, A; Dombi, E; Widemann, BC; Sint, KJ. Selumetinib in pediatric patients with neurofibromatosis type 1 and plexiform neurofibroma: Propensity score analysis of SPRINT vs. natural history control arm. Neuro-Oncology Advances. 2025; 7(1):vdaf101.

Almohtasib, J; Indelicato, DJ; Paulino, AC; Mihalcik, S; Lee, J; Ermoian, R; Chang, JH-C; Kwok, Y; Perentesis, J; Perkins, SM; Hill-Kayser, C; Zeina, W; Laack, NN; Yock, TI; Gargollo, PC. Assessing Acute and Long-Term Toxicities of Proton Radiation Therapy in Pediatric Pelvic Tumors: Findings From the Pediatric Proton Consortium Registry. Pediatric Blood and Cancer. 2025; 72(10):e31811.

Armstrong, AE; Daw, NC; Renfro, LA; Geller, JI; Kalapurakal, JA; Khanna, G; Paulino, AC; Perlman, EJ; Ehrlich, PF; Gow, KW; Warwick, AB; Grundy, PE; Fernandez, CV; Mullen, EA; Dome, JS. Treatment of focal anaplastic Wilms tumor: A report from the Children's Oncology Group AREN0321 and AREN03B2 studies. Cancer. 2025; 131(2):e35713.

Avery, R; Listernick, R; De Blank, P; Liu, G; Ferner, R; Gutmann, D; Fisher, M; Team, N-ONHS. 005 Baseline clinical characteristics of newly diagnosed optic pathway gliomas associated with NF1: results from the international multicenter NF1-OPG Natural History Study. Journal of AAPOS. 2025; 29(4):104287.

Avery, RA; Gross, AM; Cousineau-Krieger, C; Keenan, TDL; Mcmanus, T; Dallas, CJ; Hampton, C; Baldwin, A; Jin, F; Heisey, K; Bishop, RJ; Fisher, MJ; Widemann, BC; Magone, MT. Long-term Ocular Safety in Children Treated with Mitogen-Activated Protein Kinase Pathway Inhibitor Therapy. Ophthalmology (Rochester, Minn.). 2025.

Bacha, J; Brown, D; Geller, J; Oesterheld, J; Thompson, P; Kim, A; Mcmanus, M; Kanekal, S; Leggas, M; Lopez, L; Sankar, N; Yam, N; Wagner, L. Abstract LB266: A multicenter phase 1-2a clinical study of Orotecan® (oral irinotecan HCl, VAL-413) in patients with recurrent pediatric solid tumors. Cancer Research. 2025; 85(8_Supplement_2):lb266-lb266.

Bauchat, A; Peterson, A; Ahn, KW; Mehta, PA; Phillips, CL; Schultz, KR; Sharma, A; Broglie, L; Qayed, M. Impact of Graft Versus Host Disease Following Allogeneic Hematopoietic Cell Transplantation on Leukemia Free Survival in Hematologic Malignancies: A CIBMTR Analysis. Transplantation and Cellular Therapy. 2025; 31(2):s60-s61.

Bedard, MC; Rivera-Cruz, CM; Chihanga, T; Vonhandorf, A; Tang, AL; Zender, C; Weirauch, MT; Ferris, R; Wise-Draper, TM; Adam, M; Wells, SI. A Single-Cell Transcriptome Atlas of Epithelial Subpopulations in HPV-Positive and HPV-Negative Head and Neck Cancers. Viruses. 2025; 17(4).

Bender, J; Davies, SM; Myers, KC; Benoit, SW. Beyond Survival: Assessing Renal and Cardiovascular Health in Fanconi Anemia Adolescents and Young Adults Post-Stem Cell Transplant. Transplantation and Cellular Therapy. 2025; 31(2):s375-s376.

Benedetti, DJ; Cost, NG; Ehrlich, PF; Evageliou, N; Fialkowski, E; Parsons, LN; Vallance, KL; Renfro, LA; Hong, AL; Aldrink, JH; Treece, AL; Dome, JS; Geller, JI; Mullen, EA. Updated favourable-histology Wilms tumour risk stratification: rationale for future Children's Oncology Group clinical trials. Nature Reviews Urology. 2025; 22(11):775-788.

Boldt, A; Bender, J; Jodele, S; Davies, SM; Benoit, SW. Differential Filtration of Macromolecules: A Novel Indicator of Mortality Risk in Pediatric HSCT Patients. Transplantation and Cellular Therapy. 2025; 31(2):s145-s146.

Brown, A; Pommert, L. GATA Lot to Learn: Decoding the Drivers of Down Syndrome-Associated Acute Leukemias. The Hematologist. 2025; 22(4).

Campbell, ME; Stutzman, S; Primeaux, S; Sida, D; Lee, M; Shah, AT; Sadanand, A; Sokol, E; Collins, NB; Turpin, B; Rakheja, D; Chen, KS; Gerber, DE; Koh, AY. Feasibility of Atezolizumab in Combination With Chemotherapy for Children With Relapsed or Refractory Solid Tumors. Pediatric Blood and Cancer. 2025; 72(12):e32046.

Cha, E; Mihalcik, SA; Indelicato, DJ; Laack, NN; Ermoian, RP; Mangona, VS; Perkins, SM; Wolden, SL; Lee, JY; Perentesis, JP; Eaton, BR; Le, HV; Paulino, AC; Yock, TI. Outcomes of Patients with Intracranial Germinoma Enrolled on the Pediatric Proton Photon Consortium Registry. International Journal of Radiation Oncology Biology Physics. 2025; 123(1):e144-e145.

Chang, E; Rubinstein, J; Pommert, L. WU Hoo! The Promise of Allogeneic WU-CART-007 in Relapsed/Refractory T-Cell Malignancies. The Hematologist. 2025; 22(5).

Childress, A; Koch, A; Vallee, E; Steller, A; Raskin, S. The Current Landscape of Molecular Pathology for the Diagnosis and Treatment of Atypical Teratoid Rhabdoid Tumor. Journal of Molecular Pathology. 2025; 6(2):13.

Chohan, K; Feng, L; Cochran, H; Rosenberg, M; Isenalumhe, L; Yilmaz, E; Kim, S-H; Tiger, YK; Torka, P; Flanagan, H; Hamadani, M; Diefenbach, C; Bartlett, N; Ahmed, S. Real-world clinical outcomes with novel agent combination therapies for the frontline treatment of pediatric and adult advanced-stage Hodgkin lymphoma. Blood. 2025; 146(Supplement 1):1852-1852.

Crisler, K; Norris, R; Ketterl, T; Perentesis, J; Mcgrady, M. Social support and barriers to medication adherence among adolescents and young adults with leukemia and lymphoma. Blood. 2025; 146(Supplement 1):2706.

Curlee, MS; Toledo-Tamula, MA; Baker, M; Wikstrom, D; Harrison, C; Rhodes, A; Fagan, M; Tibery, C; Wolters, PL; Widemann, BC; Gross, AM; Martin, S. A Mixed Methods Study of Medication Adherence in Adults with Neurofibromatosis Type 1 (NF1) on a Clinical Trial of Selumetinib. Cancers. 2025; 17(2).

D'alessandro, PR; Homanick, CE; Cooper, BD; Ferguson, K; Rutan, H; Pressey, JG. "From Drowning to Treading Water": Adolescents and Young Adults Living with Incurable and Indolent Metastatic Soft Tissue Sarcoma for More than Two Years. Cancers. 2025; 17(3).

Davis, K; Molloy, E; Marks, K; Breese, E; Taylor, JM; Broomall, E; Stalets, E. 667: SEVERE METHOTREXATE-INDUCED NEUROTOXICITY IN A HISPANIC ADOLESCENT GIRL WITH B-ALL. Critical Care Medicine. 2025; 53(1).

Dela Cruz, FS; Fox, E; Dubois, SG; Friedman, GK; Croop, JM; Kim, A; Morgenstern, DA; Balis, FM; Macy, ME; Pressey, JG; He, CS; Aluri, J; Okpara, CE; Glade Bender, JL. A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors. Pediatric Blood and Cancer. 2025; 72(7):e31692.

Dombi, E; Gross, AM; Widemann, BC; Weiss, BD; Plotkin, SR; Ahlawat, S. Challenges in Assessing Response in Clinical Trials for Neurofibromatosis Type 1 Plexiform Neurofibromas. Journal of Clinical Oncology. 2025; 43(15):1843-1844.

Drucker, M; Pommert, L. When Treatment Becomes Personal: Cytarabine Pharmacogenomics Score Elucidates Outcome Disparities in Pediatric and Adolescent and Young Adult Acute Myeloid Leukemia. The Hematologist. 2025; 22(6).

Eigenbrood, J; Wong, N; Mallory, P; Pereira, JS; Williams, D; Morris-Ii, DW; Beck, JA; Cronk, JC; Sayers, CM; Mendez, M; Leblanc, AK; Cotter, J; Kaplan, RN; Mceachron, TA. Spatial Profiling Identifies Regionally Distinct Microenvironments and Targetable Immunosuppressive Mechanisms in Pediatric Osteosarcoma Pulmonary Metastases. Cancer Research. 2025; 85(12):2320-2337.

Fangusaro, J; Onar-Thomas, A; Young Poussaint, T; Lensing, S; Ligon, AH; Lindeman, N; Banerjee, A; Kilburn, LB; Lenzen, A; Pillay-Smiley, N; Jones, DTW; Stewart, CF; Fouladi, M; Dunkel, IJ. A phase 2 PBTC study of selumetinib for recurrent/progressive pediatric low-grade glioma: Strata 2, 5, and 6 with long-term outcomes on strata 1, 3, and 4. Neuro-Oncology. 2025; 27(9):2415-2428.

Fathi Kazerooni, A; Khalili, N; Liu, X; Haldar, D; Jiang, Z; Zapaishchykova, A; Pavaine, J; Shah, LM; Jones, BV; Sheth, N; Resnick, A; Bakas, S; Vossough, A; Linguraru, MG. BraTS-PEDs: Results of the Multi-Consortium International Pediatric Brain Tumor Segmentation Challenge 2023. MELBA journal. 2025; 3(June 2025):72-87.

Faulk, KE; Kairalla, JA; Hibbitts, E; Long-Boyle, J; Devidas, M; August, A; Gore, L; Raetz, E; Hunger, SP; Loh, ML; Teachey, DT; Brown, P; Breese, EH; Kotecha, RS; Guest, E. Age-based pegaspargase dosing is safe and achieves therapeutic levels in infants with ALL: report from COG AALL15P1. Blood advances. 2026; 10(1):70-74.

Fernandez, K; Hoetink, A; Konrad-Martin, D; Berndtson, D; Clark, K; Dreisbach, L; Geller, JI; Goffi-Gomez, MV; Grosnik, A; Jamis, C; Sanchez, VA; Van Den Heuvel-Eibrink, MM; Brewer, CC; Poling, GL. Roadmap to a Global Template for Implementation of Ototoxicity Management for Cancer Treatment. Ear and Hearing. 2025; 46(2):286-297.

Freyer, DR; Ohlsen, TJD; Don, D; Orgel, E; Hayashi, RJ; Lieu, JE; Foster, JH; Sitton, MS; Geller, JI; Choo, DI; Grunstein, E; O'neill, AF; Rahbar, R; Anderson, JJ. Feasibility and Safety of Intratympanic Administration of Sustained-Exposure Dexamethasone Thermosensitive Gel (OTO-104) for Prevention of Cisplatin-Induced Hearing Loss in Children: A Multisite Phase 2 Randomized Clinical Trial. Pediatric Blood and Cancer. 2025; 72(6):e31680.

Galletta, TJ; Benoit, SW; Markham, J; Pillay-Smiley, N; Queen, K; Graham, RT. Elevated Bromide Levels Due to Tazemetostat Therapy Treated With Salt and Water Supplementation in Two Children With Atypical Teratoid Rhabdoid Tumor. Pediatric Blood and Cancer. 2025; 72(8):e31803.

Garrett, MC; Carnwath, T; Albano, R; Zhuang, Y; Behrmann, CA; Pemberton, M; Barakat, F; Lober, R; Hoeprich, M; Paravati, A; Perentesis, J; Nasser, R; Medvedovic, M; Plas, DR. CPI203, a BET inhibitor, down-regulates a consistent set of DNA synthesis genes across a wide array of glioblastoma lines. PLoS ONE. 2025; 20(5):e0306846.

Geller, JI; Renfro, LA; Grundy, PE; Perlman, EJ; Kalapurakal, JA; Ehrlich, PF; Biegel, J; Huff, V; Warwick, AB; Paulino, A; Ward, DA; Anderson, JR; Fernandez, CV; Dome, JS. Rhabdoid Tumor of the Kidney and Soft Tissues: Results from National Wilms Tumor Study-5 and Children's Oncology Group Study AREN0321. Pediatric Blood and Cancer. 2025; 72(3):e31490.

Ghosh, A; Li, H; Towbin, A; Turpin, B; Trout, A. T2-weighted MRI radiomics for the prediction of pediatric and young adult rhabdomyosarcoma alveolar subtype and distant metastasis: a pilot study. Pediatric Radiology. 2025; 55(6):1149-1161.

Gilene, S; D'aquila, K; Cooper, B; Szabo, S; Pressey, JG. Dramatic multifocal osteosarcoma treatment response in the setting of POT1 tumor predisposition syndrome. Cancer Genetics. 2025; 298-299:39-43.

Gilene, S; Haacker, L; Rutan, H; Pressey, JG. The Threat of Medical Misinformation: A Case of Ivermectin Toxicity in a Pediatric Oncology Patient. Pediatric Blood and Cancer. 2025; 72(9):e31876.

Gilene, S; Knapke, S; Leino, D; Roy, S; Raskin, S. A novel POT1-TPD presentation: A germline pathogenic POT1 variant discovered in a patient with newly diagnosed posterior fossa ependymoma. Cancer Genetics. 2025; 292-293:38-43.

Gopu-Gilboy, A; Sheak, JR; Monangi, N; Damianos, A; Pommert, L. Shining a TORCH on a Case of Blueberry Muffin Rash in a Newborn Infant. NeoReviews. 2025; 26(3):e191-e196.

Graff, Z; Pommert, L. DARA to Believe: Anti-CD38 Antibody Improves Outcomes in Relapsed/Refractory Pediatric T-Cell Lymphoblastic Leukemia and Lymphoma. The Hematologist. 2025; 22(3).

Gross, AM; Reid, OH; Baldwin, LA; Cannon, A; Choo-Wosoba, H; Steinberg, SM; Lobbous, M; Wolters, PL; Pichard, DC; Tibery, CM; Dombi, E; Derdak, J; Widemann, BC; Korf, BR. Treatment of Cutaneous Neurofibromas in Neurofibromatosis Type 1 With MEK Inhibitor Selumetinib: A Nonrandomized Clinical Trial. JAMA dermatology. 2025; 161(5):533-537.

Gross, AM; O'sullivan Coyne, G; Dombi, E; Tibery, C; Herrick, WG; Martin, S; Angus, SP; Shern, JF; Rhodes, SD; Foster, JC; Srivastava, AK; Doroshow, JH; Chen, AP; Widemann, BC. Selumetinib in adults with NF1 and inoperable plexiform neurofibroma: a phase 2 trial. Nature Medicine. 2025; 31(1):105-115.

Hall, AD; Hendricks, HA; Bowers, KA; Geller, JI; Bondoc, AJ; Tiao, GM; Taylor, AE; Otto, WR; Paulsen, GC; Danziger-Isakov, LA. Impact of Hepatoblastoma on Infectious Complications Following Pediatric Liver Transplantation. Pediatric Transplantation. 2025; 29(1):e70035.

Haney, M; Devine, KJ; Xavier, AC; Ford, JB; Audino, AN; Villagomez, L; Kebede, A; Rubinstein, JD. Posttransplant EBV-Positive Smooth Muscle Tumors in Children, Adolescents, and Young Adults: A Multi-Institution Experience. Pediatric Blood and Cancer. 2025; 72(6):e31678.

Hoeksema, P; Hayatghaibi, S; Sharp, SE; Li, Y; Anton, CG; Norris, RE; Trout, AT. Discrepancies between primary and secondary interpretations of pediatric nuclear medicine imaging examinations. Pediatric Radiology. 2025.

Hoyt, SB; Finocchio, CJ; Croll, E; Tawa, GJ; Zhang, M; Wang, J; Li, H; Ma, L; Li, K; Zhang, X; Culver-Cochran, AE; Rosenbaum, JS; Starczynowski, DT; Thomas, CJ. IRAK1/4/pan-FLT3 Kinase Inhibitors with Reduced hERG Block as Treatments for Acute Myeloid Leukemia. ACS Medicinal Chemistry Letters. 2025; 16(5):887-895.

Ismail, M; Um, H; Pytel, N; Salloum, R; Rebsamen, S; De Blank, P; Tiwari, P. IMG-71. Stability of radiomics in pediatric medulloblastoma: a multi-institutional preliminary analysis. Neuro-Oncology. 2025; 27(Supplement_5):v289-v290.

Ismail, M; Um, H; Pineda, G; Salloum, R; Hollnagel, F; Ahmed, R; De Blank, P; Tiwari, P. Radiomic-based prognostic score for survival risk-stratification in pediatric medulloblastoma tumors: A multi-institutional study. Neuro-Oncology Advances. 2025; 7(1):vdaf107.

Johnstone, ME; Leck, AL; Lange, TE; Wilcher, KE; Shephard, MS; Paranjpe, A; Schutte, S; Wells, SI; Kappes, F; Salomonis, N; Privette Vinnedge, LM. DEK promotes mammary hyperplasia and is associated with H3K27me3 epigenetic modifications. Life Science Alliance. 2025; 8(9).

Jones, L; Khadaroo, A; Tiwari, R; Choi, K; Adam, M; Wunderlich, M; Stillwell, C; Sexton, C; Seibel, W; Tawa, G; Hoyt, S; Thomas, C; Starczynowski, D. FLT3-F691L confers kinase-independent resistance via Grb2-dependent MAPK signaling in AML. Blood. 2025; 146(Supplement 1):5049-5049.

Kelleher, JA; Bernstein, JL; Crisler, KM; Herriott, JK; Klages, KL; Norris, RE; Strenk, ML; Bills, SE; Mcgrady, ME. Patient-Level Barriers and Facilitators to Inpatient Physical Therapy in Adolescents and Young Adults With a Hematological Malignancy: A Qualitative Study. Pediatric Blood and Cancer. 2026; e70129.

Kim, A; Ballman, KV; Wolters, PL; Heise, RS; Shern, JF; Sundby, RT; Lindenberg, L; Lee, M-J; Rastogi, S; Sato, N; Gross, AM; Reinke, D; Cichowski, K; Widemann, BC. SARC031: A Phase 2 Trial of Selumetinib and Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors (MPNST). Clinical Cancer Research. 2026.

Kirstein, A; Ionascu, D; Lamba, MAS; Ruffolo, BM; Crail, KJ; Mascia, AE; Sertorio, MG; Hinrichs, BH; Zender, C; Lehn, MA; Wise-Draper, TM; Perentesis, JP; Zheng, Y; Wells, SI. In vitro determination of patient-specific variation challenges the universal RBE gold standard for proton radiation therapy. Clinical and Translational Radiation Oncology. 2026; 56:101046.

Klages, KL; Gibson, CA; Barnett, KA; Schwartz, LE; Hicks, CA; Norris, RE; Kashikar-Zuck, S; Pai, ALH. Systematic Review of Pain Assessment Measures Used in Pediatric Acute Lymphoblastic Leukemia. Psycho-Oncology. 2025; 34(1):e70063.

Koch, A; Derinkuyu, B; Webster, A; Mochizuki, A; Pillay-Smiley, N; Graham, RT. BIOM-88. LEPTOMENINGEAL METASTASIS IN THE INTERNAL AUDITORY CANAL AS A PREDICTOR OF OUTCOMES FOR CHILDREN WITH CENTRAL NERVOUS SYSTEM TUMORS. Neuro-Oncology. 2025; 27(Supplement_5):v45-v45.

Koch, A; Childress, A; Vallee, E; Steller, A; Raskin, S. The Current Landscape of Molecular Pathology for the Diagnosis and Treatment of Pediatric Medulloblastoma. Journal of Molecular Pathology. 2025; 6(2):11.

Kotch, C; Gomes, A; Schatz, KS; Dombi, E; Brown, S; Gross, AM; Alves, M; Perreault, S; Mueller, S; Reddy, AT; Tonsgard, J; Weiss, BD; Widemann, B; Fisher, MJ. The spectrum of pathogenic NF1 variants in participants enrolling on clinical trials of MEK inhibitors for plexiform neurofibroma. Human Genetics. 2025; 144(11-12):1199-1206.

Kraft, IL; Akshintala, S; Gross, A; Dombi, E; Turkbey, B; Bednarova, S; Ward, JF; Yedururi, S; Merino, M; Pinto, PA; Widemann, BC; Shern, JF; Waguespack, SG; Glod, J. The Prostate is a Common Site of Disease in Patients with MEN2B and Medullary Thyroid Carcinoma. Endocrine-Related Cancer. 2025.

Krisch, JM; Ermoian, RP; Indelicato, DJ; Lee, JY; Perentesis, JP; Perkins, SM; Laack, NN; Chang, JH; Macewan, IJ; Wolden, SL; Wang, D; Yock, TI; Aridgides, PD. Outcomes following radiation therapy for embryonal tumor with multilayered rosettes (ETMR): results from the Pediatric Proton/Photon Consortium Registry (PPCR). Journal of Neuro-Oncology. 2025; 174(2):369-380.

Kurtz, K; Ma, E; Chi, Y-Y; Malvar, J; Tan, Y; Schafer, E; Pauly, M; Kaplan, J; Pommert, L; Rossoff, J; Graff, Z; Shin-Kashiyama, E; Wayne, A; Bhojwani, D. Identifying barriers to clinical trial enrollment for children with relapsed or refractory hematologic malignancies. Blood. 2025; 146(Supplement 1):4404-4404.

Lafay-Cousin, L; Cansanay, D-R; Erker, C; Ratterman, E; Schlosser, MP; Nobre, L; Ronsley, R; Magimairajan, V; Pillay-Smiley, N; Cluster, A; Robinson, G; Dufour, D; Rutkowski, S; Bouffet, E. Medulloblastoma of early childhood. Salvage and outcome after initial CSI sparing approaches. OncoDaily Medical Journal. 2025.

Lamoureux, A-A; Fisher, MJ; Lemelle, L; Pfaff, E; Amir-Yazdani, P; Kramm, C; De Wilde, B; Kazanowska, B; Hutter, C; Pfister, SM; Jones, C; Doz, F; Laetsch, TW; Perreault, S. Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions. Clinical Cancer Research. 2025; 31(3):561-572.

Lange, KR; De Blank, P; Xing, M; Mirzaei, S; Srivastava, DK; Oeffinger, K; Neglia, J; Krull, K; Nathan, PC; Howell, R; Armstrong, GT; Brinkman, T; Bowers, DC; Okcu, MF. Late Morbidity and Mortality in Survivors of Childhood Ependymoma: A Report from the Childhood Cancer Survivor Study (CCSS). Cancers. 2025; 17(22).

Lazow, M; Bobbey, A; Szabo, S; Fuller, C; White, W; Mcneely, D; Gibson, L; Brady, S; Palmer, J; Mardis, E; Troyer, K; Fouladi, M; Salloum, R; Trout, A. IMGP-04. Targetable somatostatin receptor expression assessed by DOTATATE PET imaging in children and young adults with recurrent/progressive high-risk central nervous system (CNS) tumors: Initial screening results from the CONNECT2007 Lutathera Phase I/II trial. Neuro-Oncology. 2025; 27(Supplement_5):v311-v311.

Lemberg, KM; Gross, AM; Sproule, LM; Liewehr, DJ; Dombi, E; Baldwin, A; Steinberg, SM; Bornhorst, M; Lodish, M; Blakeley, JO; Widemann, BC. Anthropometric measurements of children with neurofibromatosis type I: impact of plexiform neurofibroma volume and treatment. Pediatric Research. 2025; 97(6):1918-1928.

Levine, AB; Bennett, J; Patil, P; Burns, I; Siddaway, R; Li, C; Haizel-Cobbina, J; Rana, M; Yuditskiy, R; Son, A; Rutka, JT; Dewan, MC; Tabori, U; Hawkins, CE. Integrated clinical and molecular landscape of disseminated pediatric low-grade glioma. Neuro-Oncology. 2025.

Li, J; Merkel, E; Grier, D; Zimmermann, N; Hodjat, P; Sabharwal, S; Breese, EH; Lorsbach, RB. Maternal-Fetal Transmission of Diffuse Large B-Cell Lymphoma. Pediatric Blood and Cancer. 2025; e32174.

Lichtenstein, DA; Sridharan, A; Khoury, R; Grimley, MS; Rubinstein, JD; Lutzko, CM; Wang, YM. Effect of Clinically Relevant Immunosuppressants on Viral Specific T-Cell (VST) in Vitro Function. Transplantation and Cellular Therapy. 2025; 31(2):s509-s510.

Lin, AM; Bergus, KC; Bricker, J; Fallat, M; Hertweck, SP; Hewitt, G; Lutz, C; Aldrink, JH; Bence, C; Breech, L; St Peter, SD; Asti, L; Deans, K; Minneci, PC. Use of Ovarian Tumor Markers in Prediction of Malignancy Risk in Pediatric and Adolescent Patients. Journal of Surgical Research. 2025; 315:839-846.

Little, P; Al Ghriwati, N; Siegel, A; Toledo-Tamula, MA; Curlee, MS; Baker, M; Rogge, RD; Yohe, M; Gross, A; Martin, S. A Pilot Acceptance and Commitment Intervention for Parents of Children With RASopathies. Clinical Practice in Pediatric Psychology. 2025; 13(1):37-48.

Lucas, C-HG; Gross, AM; Romo, CG; Dehner, CA; Lazar, AJ; Miettinen, M; Pekmezci, M; Quezado, M; Rodriguez, FJ; Stemmer-Rachamimov, A; Viskochil, D; Perry, A. Consensus recommendations for an integrated diagnostic approach to peripheral nerve sheath tumors arising in the setting of Neurofibromatosis Type 1. Neuro-Oncology. 2025; 27(3):616-624.

Mcgrady, ME; Ketterl, TG; Webster, RT; Burns, MMK; Bills, SE; Burke, M; Szulczewski, L; Brock, MY; Schwartz, LE; Herriott, JK; Hommel, KA; Pai, ALH; Mara, CA; Norris, RE. Feasibility Trial of a Tailored Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer. Pediatric Blood and Cancer. 2026; 73(1):e32127.

Mcgrady, ME; Webster, RT; Burke, M; Gomez, C; Breen, G; Herriott, JK; Norris, RE; Ketterl, TG. Developing Behavior Change Model-Informed and Participant-Engaged Retention Strategies for Adolescents and Young Adults With Cancer Enrolled on Behavioral and/or Psychosocial Trials. Pediatric Blood and Cancer. 2025; 72(5):e31583.

Mehta, PA; Nelson, A; Loveless, S; Lane, A; Fukuda, T; Teusink-Cross, A; Elder, D; Lagory, D; Miller, E; Cancelas, JA; Edwards, S; Chihanga, T; Wells, SI; Davies, SM. Phase 1 study of quercetin, a natural antioxidant for children and young adults with Fanconi anemia. Blood advances. 2025; 9(8):1927-1939.

Moscato, EL; Fisher, AP; Patronick, J; Pillay-Smiley, N; Gerhardt, CA; Salloum, R; Wade, SL. Quality of Life for Rural and Appalachian Pediatric Brain Tumor Survivors in Ohio and Kentucky. Clinical Practice in Pediatric Psychology. 2025; 13(1):11-16.

Nguyen, P; Indelicato, DJ; Esterman, A; Paulino, AC; Ermoian, RP; Laack, NN; Perkins, SM; Mangona, V; Mihalcik, S; Lee, J; Perentesis, JP; Macewan, I; Le, H; Yock, TI. Acute Toxicities of Proton Craniospinal Irradiation in Pediatric Medulloblastoma: A Pediatric Proton/Photon Consortium Registry (PPCR) Study. International Journal of Particle Therapy. 2025; 16:100747.

Papini, C; Mirzaei, S; Xing, M; Tonning Olsson, I; Salloum, R; De Blank, PMK; Lange, KR; King, TZ; Srivastava, D; Leisenring, WM; Robison, LL; Armstrong, GT; Krull, KR; Brinkman, TM. Neurocognitive outcomes and functional independence in adult survivors of childhood medulloblastoma diagnosed over 3 decades. Neuro-Oncology. 2025; 27(1):254-266.

Parisi, R; Dhulipalla, S; Widemann, B; Pichard, DC; Gross, A; Weintraub, L. 61430 Dermatologic adverse events in neurofibromatosis patients on MEK inhibitors. Journal of American Academy of Dermatology. 2025; 93(3):ab33.

Perotti, D; O'sullivan, MJ; Walz, AL; Davick, J; Al-Saadi, R; Benedetti, DJ; Brzezinski, J; Ciceri, S; Cost, NG; Dome, JS; Spreafico, F; Geller, JI; Van Den Heuvel-Eibrink, MM; Hong, AL. Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers. Nature Reviews Urology. 2025; 22(8):526-543.

Pommert, L; Tasian, SK. ‘Blin’-ing Is Winning for Children With B-Cell Acute Lymphoblastic Leukemia. The Hematologist. 2025; 22(1).

Pressey, JG; Toebbe, B; Chandler, M; Szabo, S; Pitt, S. 23P Pre-diagnostic imaging reveals rapid emergence and progression of small cell carcinoma of the ovary hypercalcemic type (SCCOHT): Implications for monitoring carriers of SMARCA4 germline pathogenic variants (GPVs) ESMO Open. 2025; 10:104332.

Pruitt, DW; Bolikal, PD; Haas, M. Rehabilitation of the Pediatric Cancer Patient. In: Cancer Rehabilitation. Springer Publishing Company; 2025.

Raskin, S; Yang, C; Lin, T; Yearley, J; Blumenschein, W; Pillay-Smiley, N; Lenzen, A; Partap, S; Fangusaro, J; Gururangan, S; Onar-Thomas, A; Fouladi, M; Dunkel, I; Mitchell, D; Hwang, E. IMMU-79. An Updated Analysis of PD1 and Immune Pathway Activity in Malignant Pediatric Central Nervous System (CNS) Tumors: A Pediatric Brain Tumor Consortium (PBTC) Study, PBTC-N13. Neuro-Oncology. 2025; 27(Supplement_5):v221-v221.

Raskin, S; De Blank, P; Billups, CA; Li, Y; Olson, JM; Leary, SES. Isotretinoin has no effect on event-free survival across high-risk medulloblastoma molecular groups when added to maintenance: A secondary analysis of the Children's Oncology Group ACNS0332 data. Neuro-Oncology Advances. 2025; 7(1):vdaf054.

Reed, HD; Do, H; Weller, E; Harris, MH; Reilly, CR; Tsai, HK; Farrar, JE; Lau, BW; Pommert, L; Gamper, C; Cheng, L; Malsch, M; Myers, K; Shimamura, A. Lymphoid malignancies in patients with Shwachman-Diamond syndrome. Blood. 2025; 145(21):2528-2532.

Renfro, LA; Vallance, KL; Tfirn, IC; Evageliou, N; Benedetti, DJ; Shamberger, RC; Ehrlich, PF; Cost, NG; Aldrink, JH; Schechter, A; Fernandez, CV; Dome, JS; Geller, JI; Mullen, EA. Associations of Patient Age, Tumor Nephrectomy Weight, and Tumor Diameter with Event-Free and Overall Survival in Stage I or II Favorable Histology Wilms Tumor: A Pooled Analysis of Children's Oncology Group Studies AREN0532 and AREN03B2. Annals of Surgery. 2025.

Rouce, RH; Dolan, JG; Phillips, CL; Qayed, M; Pulsipher, MA; Vernau, LM; Galletta, TJ; Votaw, S; Caraballo, GL; Yang, H; Tesfaye, M; Lee, S; O'sullivan, E; Grupp, SA. Kymriah Real-World Effectiveness and Functional Persistence in Acute Lymphoblastic Leukemia (ALL) (KareALL): A Retrospective Analysis of the Effect of Current Tisagenlecleucel (tisa-cel) Manufacturing in Pediatric and Young Adult Patients (pts) with ALL. Transplantation and Cellular Therapy. 2025; 31(2):s219.

Ruffolo, B; Vicente-Muñoz, S; Mehta, KY; Rivera-Cruz, CM; Zhao, X; Romick, L; Setchell, KDR; Lane, A; Wells, SI. The Fanconi Anemia Pathway Inhibits mTOR Signaling and Prevents Accelerated Translation in Head and Neck Cancer Cells. Cancers. 2025; 17(15).

Salamon, J; Widemann, BC; Gross, AM; Baldwin, A; Farschtschi, SC; Mautner, VF; Dombi, E. Malignant peripheral nerve sheath tumors in neurofibromatosis type 1 arise from distinct nodular lesions: A retrospective imaging analysis. Neuro-Oncology Advances. 2025; 7(1):vdaf201.

Sarangdhar, M; Snyder, J; O'brien, E; Vancauwenbergh, B; Basu, M; Pressey, J; Perentesis, J. Abstract 3155: High-throughput drug repositioning identifies dinaciclib as a potent osteosarcoma inhibitor. Cancer Research. 2025; 85(8_Supplement_1):3155-3155.

Sargen, MR; Fitzhugh, MH; Ko, JS; Close, AG; Horton, SC; Malik, F; Furtado, LV; Bahrami, A; Seynnaeve, BKN; Pappo, AS; Gross, AM; Kaplan, R; Yohe, ME; Berrebi, KG. Clinicopathologic Features, Management, and Outcomes Of Pediatric CRTC1::TRIM11 and MED15::ATF1 Tumors With Spitzoid Morphology: A Case Series. Pediatric Blood and Cancer. 2025; 72(8):e31814.

Schmid, I; O’Neill, AF; Watanabe, K; Aerts, I; Branchereau, S; Brock, PR; Dandapani, M; Fresneau, B; Geller, J; Hishiki, T; Zsiros, J; Hiyama, E; Malogolowkin, M; Ansari, M. Global consensus from the PHITT consortium surrounding an interim chemotherapy guidance for the treatment of children with hepatoblastoma, hepatocellular neoplasm – not otherwise specified (HCN-NOS), hepatocellular carcinoma and fibrolamellar carcinoma after trial closure. EJC Paediatric Oncology. 2025; 5:100235.

Schuemann, J; Rothwell, B; Mascia, A; Fan, Y; Loo, BW; Yock, T; Liu, KX; Perentesis, J; Haas-Kogan, DA. The potential and risks of FLASH radiotherapy in pediatric patients. Neuro-Oncology Pediatrics. 2025.

Segal, J; Cronk, J; Ball, B; Forbes, G; Jackett, K; Li, K; Osorno, AM; Montalvan, ESA; Browne, A; Lake, J; Kaplan, RN. Parallels in Canonical Developmental Signaling Pathways between Normal Development and the Tumor Microenvironment. Cold Spring Harbor Perspectives in Medicine. 2025.

Sirhan, Z; Sells, BE; Fleming, JL; Manring, H; Graham, RT; Haque, J; Showalter, CA; Singh, K; Marchal, NS; Mcelroy, J; Boue, DR; Becker, AP; Finlay, JL; Chakravarti, A. PA2G4 as a Candidate Therapeutic Target in Pediatric Diffuse Gliomas. International Journal of Radiation Oncology Biology Physics. 2025; 123(1):e510.

Steller, A; Childress, A; Koch, A; Vallee, E; Raskin, S. The Current Landscape of Molecular Pathology for the Diagnosis and Treatment of Ependymoma. Journal of Molecular Pathology. 2025; 6(3):23.

Streefkerk, N; Masroor, A; Geller, JI; Van Grotel, M; Ansari, M; Bouffet, E; Bleyer, A; Fresnau, B; Sullivan, M; Huitema, ADR; Veal, GJ; Brock, PR; Meijer, AJM; Van Den Heuvel-Eibrink, MM. Local application of sodium thiosulfate as an otoprotectant for cisplatin-exposed patients – A narrative literature review to explore the potential benefit for children with cancer. EJC Paediatric Oncology. 2025; 5:100211.

Sutton, KS; Walz, AL; Groenendijk, A; Murphy, AJ; Pater, L; Janssens, GO; Brzezinski, J; Mullen, EA; Spreafico, F; Godzinski, J; Ehrlich, PF; Furtwangler, R; Brok, J; Geller, J. Remaining Challenges in the Treatment of Relapsed Wilms Tumor: Children's Oncology Group and International Society of Paediatric Oncology Perspectives. Pediatric Blood and Cancer. 2025; 72(8):e31790.

Tracy, ET; Engwall, A; Brown, EG; Sun, RC; Walther, A; Beckhorn, CB; Lal, D; Rothstein, DH; Roach, J; Cost, N; Rich, BS; Ehrlich, PF; Aldrink, JH; Rodeberg, D. Essential Knowledge and Skills for the Practice of Pediatric Surgical Oncology: A Modified Delphi Consensus Study by the APSA Cancer Committee. Annals of Surgical Oncology. 2025; 32(8):5752-5771.

Trobaugh-Lotrario, AD; O'neill, AF; Belmonte, KA; Malogolowkin, MH; Tiao, GM; Geller, JI. Characteristics of patients with liver tumors deemed ineligible for enrollment on Children's Oncology Group trial AHEP1531: An opportunity to expand inclusion criteria and improve outcome. Pediatric Blood and Cancer. 2025; 72(1):e31389.

Uible, EE; Choi, I; Clough, CA; Hassan, A; Anandappa, AJ; Fisher, J; Karki, B; Hueneman, K; Choi, K; Vick, EJ; Pasare, C; Cunningham, JT; Volk, AG; Starczynowski, DT. Scaffolding-dependent CASP1 constrains excessive cell-intrinsic inflammatory signaling in leukemia. Cell Chemical Biology. 2026.

Vallee, E; Steller, A; Childress, A; Koch, A; Raskin, S. The Current Landscape of Molecular Pathology for the Diagnosis and Treatment of Pediatric High-Grade Glioma. Journal of Molecular Pathology. 2025; 6(3):17.

Vicente-Muñoz, S; Summer, SS; Galletta, TJ; Mehta, KY; Lane, AN; Davies, SM; Romick, LE. Metabolic reprogramming in Fanconi anemia: Evidence of compromised glucose oxidation, enhanced ketogenesis, and metabolic inflexibility. Science Advances. 2025; 11(48):eady6117.

Wade, I; Witkowski, L; Ahmed, A; Rowlands, CF; Banerjee, S; Pressey, JG; Mcveigh, TP; Tischkowitz, MD; Foulkes, WD; Turnbull, C. Using cancer phenotype sex-specificity to enable unbiased penetrance estimation of SMARCA4 pathogenic variants for small cell carcinoma of the ovary, hypercalcemic type (SCCOHT). Genetics in Medicine. 2025; 27(1):101287.

Williams, MT; Regan, SL; Fritz, AL; Gollaway, BM; Mascia, AE; Vatner, RE; Perentesis, JP; Vorhees, CV. Effects of whole brain proton irradiation at conventional or ultra-high dose rate (FLASH), in adult male Sprague Dawley rats. Scientific Reports. 2025; 15(1):10602.

Zheng, DJ; Hettinger, G; Bender, JD; Boulter, AC; Cao, L; Elgarten, CW; Fisher, BT; Gathers, C; Huang, Y-SV; Ko, J; Seif, AE; Vasileiadi, E; Aplenc, R; Getz, KD. National Trends in Dexrazoxane and Cardiovascular Health Care Utilization for Children With Acute Myeloid Leukemia. JAMA Oncology. 2025; 11(12):1545-1548.

Zorn, K; Pommert, L. First Relapse, Second Chance: Determinants of Survival After First Relapse in Pediatric Acute Lymphoblastic Leukemia. The Hematologist. 2025; 22(2).